Nội dung được cung cấp bởi Bryn Mawr Communications (BMC) and Retina Today. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Bryn Mawr Communications (BMC) and Retina Today hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Player FM - Ứng dụng Podcast
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
New Retina Radio by Eyetube
Đánh dấu tất cả (chưa) nghe ...
Manage series 2134816
Nội dung được cung cấp bởi Bryn Mawr Communications (BMC) and Retina Today. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Bryn Mawr Communications (BMC) and Retina Today hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
New Retina Radio is a place to hear stories about retina that are told nowhere else.
…
continue reading
191 tập
Đánh dấu tất cả (chưa) nghe ...
Manage series 2134816
Nội dung được cung cấp bởi Bryn Mawr Communications (BMC) and Retina Today. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Bryn Mawr Communications (BMC) and Retina Today hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
New Retina Radio is a place to hear stories about retina that are told nowhere else.
…
continue reading
191 tập
Tất cả các tập
×N
New Retina Radio by Eyetube

1 Rates of Ocular AEs After Faricimab Injection 18:13
18:13
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích18:13
What are the real-world safety data following administration of faricimab (Vabysmo, Genentech)? Maura Di Nicola, MD, and guests Sruthi Arepalli, MD, and Barton Blackorby, MD, review data from a real-world, single-center, retrospective study of approximately 4500 injections of faricimab in over 700 patients at Wills Eye Hospital. What did the data show? And do these data effect the clinical patterns of Drs. Di Nicola, Arepalli, and Blackorby?…
N
New Retina Radio by Eyetube

1 Treating Geographic Atrophy (GA) In Your Practice 19:18
19:18
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích19:18
Sponsored by Apellis Pharmaceuticals. Scott Walter, MD, and Esther Kim, MD, join John W. Kitchens, MD, to discuss how they treat GA in their practices. Listen to gain expert insights as Drs. Kim, Walter, and Kitchens each share their experiences with this treatment. They also share best practices for dosing based on trial data.…
N
New Retina Radio by Eyetube

1 Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy 22:07
22:07
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích22:07
Sponsored by Apellis Pharmaceuticals. John W. Kitchens, MD, invites Scott Walter, MD, and Esther Kim, MD, to discuss best practices for identifying appropriate patients with GA for treatment. Gain perspectives on patient selection, patient education, and safety considerations.
N
New Retina Radio by Eyetube

1 Using OCT Angiography to Distinguish RVO and RAO 17:36
17:36
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích17:36
How can OCT angiography help retina specialists distinguish between retinal vein occlusion (RVO) and retinal artery occlusion (RAO) in patients who present without acute findings? Using real-world cases as a backdrop, Yasha Modi, MD, and Kat Talcott, MD, discuss Dr. Modi’s approach to distinguishing RVO and RAO via OCT angiography and review which specific OCT angiography findings may indicate referral to cardiology. Later in the episode, they explore the utility and limitations of OCT angiography in patients with diabetic retinopathy. This episode is supported by Zeiss Professional Education.…
N
New Retina Radio by Eyetube

1 OCT Angiography in a Real-world CSR Case 17:59
17:59
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích17:59
What role can OCT angiography play in tracking the development of central serous retinopathy (CSR)? Yasha Modi, MD, and Kat Talcott, MD, review the use of OCT angiography in a real-world CSR case, discuss the value of selecting OCT angiography over fluorescein angiography for patients with neovascularization, and parse which populations are not a good fit for OCT angiography. This episode is supported by Zeiss Professional Education.…
N
New Retina Radio by Eyetube

1 Switching from Aflibercept to Faricimab in Wet AMD Patients 22:00
22:00
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích22:00
Does switching wet AMD patients from aflibercept (Eylea, Regeneron) to faricimab (Vabysmo, Genentech) improve disease outcomes? Join Ben Young, MD, MS, and his guests Lediana Goduni, MD, and Joshua Uhr, MD, as they explore this a recent peer review paper on this question. What are the potential benefits of such a switch? How should providers use findings such as these to inform their practice? And are significant improvements in anatomy relevant if vision gains are unchanged?…
N
New Retina Radio by Eyetube

1 GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment? 16:50
16:50
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích16:50
What are the benefits and limitations to FDA-approved therapies for geographic atrophy? John Kitchens, MD, is joined by Saradha Chexal, MD, and Geeta Lalwani, MD, as they explore which patients are best suited for treatment, how best to succinctly set expectations for outcomes, and whether patients on GA therapy may also be well-suited AREDS vitamins.…
N
New Retina Radio by Eyetube

1 AAO '24: Real-world PDR Treatment vs. Protocol S Guidelines, and Retinal Imaging for Alzheimer's 31:38
31:38
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích31:38
How many real-world patients with proliferative DR were concordant with the treatment directions in Protocol S? Adrienne Scott, MD, explains how a database review of real-world patients with proliferative DR revealed how few patients are concordant with the strict dosing schedule of Protocol S, and shares which baseline factors were linked to lack of concordance. And Dilraj Grewal, MD, provides an update on the relationship between retinal imaging and detection of Alzheimer disease. Just how close are we from using noninvasive retinal imaging techniques to screen for potential neurodegenerative conditions?…
N
New Retina Radio by Eyetube

1 New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk? 15:01
15:01
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích15:01
Does metformin use reduce the risk of developing AMD in non-diabetic patients? Moderator Rebecca Soares, MD, and panelists Matt Starr, MD, and Nikisha Kothari, MD, review a decade-long case control-control study assessing risk of AMD in non-diabetic patients who have been taking metformin for any reason. They ask whether the study's blindspots undercut its findings, and speculate what other questions further research could answer.…
N
New Retina Radio by Eyetube

1 AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GA 20:02
20:02
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích20:02
We’ve got to keep our eye on the pipeline. What do the latest data tell us about two drug candidates? Durga Borkar, MD, MMCi, reviews data from a phase 2 study assessing the safety and efficacy ONL1204 (ONL Therapeutics) delivered prior to RRD surgery. Did injecting ONL1204, which prevents Fas activation, lead to any postsurgical differences? Alex Melamud stops by to discuss the phase 2/3 SAGA study assessing the safety and efficacy of gildeuretinol (Alkeus Pharmaceuticals), an oral agent for the treatment of geographic atrophy. Can this drug succeed where other oral options in retina have failed?…
N
New Retina Radio by Eyetube

1 AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD 25:27
25:27
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích25:27
The ELEVATUM study exclusively enrolled historically underrepresented patients in a study assessing faricimab (Vabysmo, Genentech/Roche) for DME. Were there any surprises in the data? Jeremiah Brown, MD, MS, sits down with New Retina Radio to review the philosophy behind the ELEVATUM study, discuss the study’s findings, and preview the next phases of the trial. And Eric Schneider, MD, joins the program to discuss the findings of a pivotal study assessing home OCT (Scanly, Notal Vision) in wet AMD patients. Is home OCT equivalent to in-office OCT when it comes to visualization? And do expert graders agree with an AI algorithm’s assessments of patient’s pathology?…
N
New Retina Radio by Eyetube

1 AAO '24: COVID and Retinal Disease, Plus the Latest on Step Therapy and Declining Reimbursement 31:12
31:12
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích31:12
Are retina doctors seeing more retinal pathology following infection or vaccination? Or is there nothing to see here? Rahul Khurana, MD, joins us to discuss the findings of various health care database analyses seeking to clarify whether COVID infection or vaccination were linked to retinal manifestations. Was there a clear—or even an opaque—connection between the two? And Paul Hahn, MD, PhD, sits down with us to explain how inflation, new realities of reimbursement, and step therapy directives are playing out in retina clinics in the United States. Inflation-adjusted reimbursement is declining—but can anything be done about it? And is step therapy actually saving the system any cash?…
N
New Retina Radio by Eyetube

1 GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition? 22:50
22:50
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích22:50
We finally have two FDA-approved treatments for geographic atrophy (GA)—and yet, many retina specialists have been reluctant to embrace them. Join moderator John Kitchens, MD, as he explores this question with Miguel Busquets, MD, and Esther Kim, MD. Further in the episode, they gameplan patient conversations centered around choosing a treatment, ask how heavily to weigh safety when selecting a complement inhibitor, and preview the GA pipeline.…
N
New Retina Radio by Eyetube

1 New Retina Radio Journal Club with VBS: Pre-treatment with Chlorhexidine vs. Povidone-Iodine in Endophthalmitis Prevention 16:59
16:59
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích16:59
In this episode of the New Retina Radio Journal Club with VBS, Maura Di Nicola, MD; Sruthi Arepalli, MD, and Barton Blackorby, MD, discuss a recent study comparing endophthalmitis rates following anti-VEGF injections with pre-treatment using either 5% Povidone Iodine or 0.05% Chlorhexidine. They highlight how prefilled syringes can reduce the risk of endophthalmitis and explore the implications for clinical practice, including antiseptic protocols, patient sensitivities, and how to navigate conflicting study outcomes. Tune in for valuable insights that could influence your injection protocols.…
N
New Retina Radio by Eyetube

1 Real-World Studies Reported in Lisbon: Untreated GA Progression and High-Dose Aflibercept in Wet AMD, DME, and DR 28:42
28:42
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích28:42
Tens of thousands of real-world geographic atrophy patients were analyzed in a retrospective database study. How did GA progress—and how do these data inform our understanding of GA? Ted Leng, MD, stopped by the show to share the findings from his research on the natural history of GA, which he recently delivered on the podium in Lisbon. And Michael Klufas, MD, joined us for a discussion about another real-world study. This time, it was a retrospective multicenter outcomes analysis following multiple injections of high-dose aflibercept (Eylea HD, Regeneron) for treatment of wet AMD, DME, and DR. How did treatment-naïve patients fare compared with previously treated patients? And did treatment intervals improve? Stick with us to find out. New Retina Radio is not affiliated with the official program of Retina Society.…
Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.